Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

(2009) Kojiro Shimozuma et al.   SUPPORTIVE CARE IN CANCER

Peripheral nerve damage associated with administration of taxanes in patients with cancer

(2008) Andreas A. Argyriou et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies

(2008) Sherry Wolf et al.   EUROPEAN JOURNAL OF CANCER

A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer

(2008) K. Kuroi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

(2008) Joseph A. Sparano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)

(2008) Katsumasa Kuroi et al.   SUPPORTIVE CARE IN CANCER